Ubs Group Ag A Ikido Pharma Inc. Transaction History
Ubs Group Ag
- $452 Billion
- Q3 2024
A detailed history of Ubs Group Ag transactions in A Ikido Pharma Inc. stock. As of the latest transaction made, Ubs Group Ag holds 6,880 shares of AIKI stock, worth $26,144. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,880Holding current value
$26,144% of portfolio
0.0%Shares
6 transactions
Others Institutions Holding AIKI
# of Institutions
16Shares Held
459KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA193KShares$734,8890.0% of portfolio
-
Black Rock Inc. New York, NY72.5KShares$275,5720.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny46.9KShares$178,3180.0% of portfolio
-
Geode Capital Management, LLC Boston, MA43.4KShares$164,8020.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX39.8KShares$151,3650.0% of portfolio
About AIkido Pharma Inc.
- Ticker AIKI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 5,485,100
- Market Cap $20.8M
- Description
- AIkido Pharma Inc., a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small mo...